CODAGENIX
#197 COMPANY RANKING
Codagenix Inc. is a clinical stage biotechnology company with vaccine products against influenza, respiratory syncytial virus, dengue virus, and others currently under development. Codagenix uses a computer-based algorithm, called SAVE (Synthetic Attenuated Virus Engineering) to design viral genomes that are identical to the wild type strain at the amino acid level, but make less protein in human cells. The highly attenuated viruses make excellent vaccines or oncolytics against solid tumors. Codagenix represents the next wave in vaccine technology, untethered from traditional, time-consuming and unpredictable approaches to attenuating viruses.
Since 2011
Claim This Company
Codagenix's latest news & mentions
Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.Infectious Diseases Society of America meeting, some highlights
medicalxpress.com
Tue Oct 31 2023
Infectious Diseases Society of America, Oct. 11-15
physiciansweekly.com
Tue Oct 31 2023
Codagenix Announces Presentation of Updated Preclinical CodaLytictm Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
lelezard.com
Thu Oct 26 2023
Codagenix Announces Presentation of Updated Preclinical CodaLytic™ Data at Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
finance.yahoo.com
Thu Oct 26 2023
Codagenix Receives Additional Award from US Department of Defense to Advance Development of Dengue Vaccine
finance.yahoo.com
Tue Oct 24 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
physiciansweekly.com
Wed Oct 18 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
guampdn.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
poststar.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
theindependent.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
mtstandard.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
omaha.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
tulsaworld.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
richmond.com
Tue Oct 17 2023
Signal: Project NextGen continues with $500m funding for vaccine research
pharmaceutical-technology.com
Tue Oct 17 2023
IDSA: Intranasal Live-Attenuated COVID-19 Vaccine Induces Response
sfexaminer.com
Tue Oct 17 2023
Signal: Project NextGen continues with $500m funding for vaccine research
msn.com
Mon Oct 16 2023
Biden Administration Invests $500 Million Into Future Anti-Covid Vaccines, Tech
kffhealthnews.org
Mon Oct 16 2023
News - Codagenix
thepharmaletter.com
Mon Oct 16 2023
GovCon Wire
govconwire.com
Mon Oct 16 2023
HHS Announces Over $500M in Project NextGen Awards to Support Vaccine, Tech Development Work
govconwire.com
Mon Oct 16 2023
Biden administration awards $500M for new COVID treatments
news.yahoo.com
Sun Oct 15 2023
Biden Administration Pledges $500M for Future COVID-19 Vaccine and Therapeutics Development
msn.com
Sat Oct 14 2023
Biden administration awards $500M for new COVID treatments
thehill.com
Fri Oct 13 2023
Your Next COVID Vaccine Might Not Be a Shot at All
msn.com
Fri Oct 13 2023
